Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Escalon MedicalESMC 36 Revenue per Share is $0.97 as of Mar. 2026. GuruFocus rates ESMC with a GF Score™ of 36/100 and a GF Value™ of $0.15 (Fairly Valued). The stock has 3 warning signs investors should review. Among 759 Medical Devices & Instruments companies, Escalon Medical ranks worse than 56.39% on this metric.
Escalon Medical's revenue per share for the
three
months ended in Mar. 2026 was $0.18.
Escalon Medical's revenue per share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.97.
Warning Sign:
Escalon Medical Corp revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue Per Share Growth Rate of Escalon Medical was -26.60% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 1.40% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was -4.30% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was -5.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Escalon Medical's Revenue per Share or its related term are showing as below:
ESMC'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -68.2 Med: 0.2 Max: 179.4
Current: 1.4
During the past 13 years, Escalon Medical's highest 3-Year average Revenue Per Share Growth Rate was 179.40% per year. The lowest was -68.20% per year. And the median was 0.20% per year.
ESMC's 3-Year Revenue Growth Rate is ranked worse than 56.39% of 759
companies
in the Medical Devices & Instruments industry
Industry Median: 3.8
vs ESMC: 1.40
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Escalon Medical Revenue per Share Related Terms
Escalon Medical Revenue per Share Historical Data
* Premium members only.
The historical data trend for Escalon Medical's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ESMC vs ALUR, LUDG, AEMD: Revenue per Share Comparison
For the Medical Devices subindustry, Escalon Medical's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Escalon Medical PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Escalon Medical's PS Ratio distribution charts can be found below:
* The bar in red indicates where Escalon Medical's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Escalon Medical's Revenue Per Share for the fiscal year that ended in Jun. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.97
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Escalon Medical (ESMC) has a Revenue per Share of $0.97 as of Mar. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Escalon Medical and its competitors. According to the industry distribution chart, Escalon Medical ranks #428 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 56.4%.
Is Escalon Medical's Revenue per Share too high?
Escalon Medical's current Revenue per Share is $0.97. The Medical Devices & Instruments industry median Revenue per Share is 3.80. Escalon Medical's value of $0.97 is 74.5% below this industry median. Based on the distribution chart, Escalon Medical ranks #428 out of 759 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Escalon Medical has a GF Score™ of 36/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Escalon Medical's Revenue per Share compare to ALUR and LUDG?
According to the Medical Devices & Instruments industry distribution chart, Escalon Medical ranks #428 out of 759 companies for Revenue per Share. This places Escalon Medical in the lower half of its industry. The industry median Revenue per Share is 3.80. Escalon Medical's value of $0.97 is 74.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Medical Devices & Instruments company?
The median Revenue per Share among Medical Devices & Instruments companies is 3.80, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Escalon Medical's current Revenue per Share of $0.97 is 74.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Escalon Medical and its competitors. For the Medical Devices & Instruments industry, the median Revenue per Share is 3.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Escalon Medical's current Revenue per Share is $0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Escalon Medical stock overvalued right now?
Based on GuruFocus' analysis, Escalon Medical (ESMC) is currently considered Fairly Valued. The stock's GF Value™ is $0.15, compared to a current price of $0.16 — trading 3.3% above its estimated fair value. The current Revenue per Share is $0.97 and 74.5% below the Medical Devices & Instruments industry median of 3.80. Escalon Medical's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Escalon Medical (ESMC), the current Revenue per Share is $0.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Escalon Medical (ESMC) Overvalued in 2026?
Based on GuruFocus' analysis, Escalon Medical stock appears to be overvalued.
The current stock price of $0.16 is trading 3.3% above its estimated GF Value™ of $0.15.
GuruFocus considers Escalon Medical to be Fairly Valued.
Key valuation signals for ESMC:
Revenue per Share: $0.97
GF Value™: $0.15 vs. price of $0.16 (3.3% above fair value)
Industry Position: 74.5% below the Medical Devices & Instruments median (#428 of 759)
No single metric tells the full story. See the ESMC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Escalon Medical Corp operates in the healthcare market, specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its products are A-Scans, B-Scans, UBM, Pachymeters, Ispan Intraocular Gases, Surgical Packs, Viscous Fluid Transfer Systems, and AXIS Image Management. Substantial revenue is generated from the domestic sales of products.
36GF Score
Get the complete analysis for ESMC
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESMC has been successfully added to your 
